1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL ADVANCEMENTS
5. DIGITAL BIOMARKERS MARKET BY TYPE
5.1. Introduction
5.2. Mobile Health Apps
5.3. Wearable Devices
5.4. Others
6. DIGITAL BIOMARKERS MARKET BY THERAPEUTIC AREA
6.1. Introduction
6.2. Cardiovascular Disorders
6.3. Neurological Disorders
6.4. Respiratory Disorders
6.5. Metabolic Disorders
6.6. Others
7. DIGITAL BIOMARKERS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical Companies
7.3. Healthcare Providers
7.4. Research Organizations
7.5. Others
8. DIGITAL BIOMARKERS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type
8.2.2. By Therapeutic Area
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Type
8.3.2. By Therapeutic Area
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Type
8.4.2. By Therapeutic Area
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Type
8.5.2. By Therapeutic Area
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Type
8.6.2. By Therapeutic Area
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Biofourmis Inc.
10.2. Evidation Health Inc.
10.3. ResMed Inc.
10.4. Verily Life Science LLC
10.5. Empatica Inc.
10.6. Koneska Health Inc.
10.7. Biobeat Technologies Ltd.
10.8. ActiGraph LLC
10.9. Huma Therapeutics Ltd.
10.10. Neurometrix Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations